Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease

NCT02248207 · clinicaltrials.gov ↗

COMPLETED

Status

1293

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Pramipexole

Sponsor

Boehringer Ingelheim